Suchergebnisse - "Guglielmetti, Lorenzo"

PubPharm (86)

1

Reduced critical concentration might not have improved MGIT-based DST's sensitivity to rifampicin

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Rupasinghe, P. | Ashraf, A. | Barreda, N. | +16

2

Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2024

von Günther, G. | Guglielmetti, L. | Kherabi, Y. | +54

3

Advances in antibiotic therapy for tuberculosis

enthalten in: La Revue du praticien | 2024

von Maitre, T. | Guglielmetti, L. | Robert, J. | +2

4

Nine-month, all-oral regimens for rifampin-resistant tuberculosis

enthalten in: bioRxiv.org | 2024

von Guglielmetti, L. | Khan, U. | Velasquez, G. | +38

5

Impact of the COVID-19 pandemic on the real-world diagnostic infrastructure for tuberculosis-An ESGMYC collaborative study

enthalten in: PloS one | 2024

von Paulowski, L. | Filip, R. | Jankovic Makek, M. | +6

6

Association of indicators of extensive disease and rifampin-resistant tuberculosis treatment outcomes : an individual participant data meta-analysis

enthalten in: Thorax | 2024

von Campbell, J. | Brode, S. | Barry, P. | +13

7

Recent advances in the treatment of tuberculosis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Motta, I. | Boeree, M. | Chesov, D. | +20

8

Occurrence of extrapulmonary tuberculosis is associated with geographical origin : spatial characteristics of the Frankfurt TB cohort 2013-2018

enthalten in: Infection | 2023

von Wetzstein, N. | Drummer, A. | Bockey, A. | +10

9

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis : a 2023 TBnet/RESIST-TB consensus statement

enthalten in: The Lancet. Infectious diseases | 2023

von Domínguez, J. | Boeree, M. | Cambau, E. | +54

ErratumIn: Lancet Infect Dis. 2023 Mar 28;:. - PMID 37001542

10

Efficacy and Tolerability of Concomitant Use of Bedaquiline and Delamanid for Multidrug- and Extensively Drug-Resistant Tuberculosis : A Systematic Review and Meta-Analysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Holmgaard, F. | Guglielmetti, L. | Lillebaek, T. | +3

1
2
3
4
5
6
7
8
9
Nächster »
[9]